Nello Mainolfi - 18 Jun 2024 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce N. Jacobs, as Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 18 Jun 2024
Net transactions value: +$29,979
Form type: 4
Filing time: 20 Jun 2024, 08:30:03 UTC
Previous filing: 04 Mar 2024
Next filing: 01 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$29,979	+14,413	+2.3%	$2.08^*	631,186	18 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-14,413	-2.8%	$0.000000	505,559	18 Jun 2024	Common Stock	14,413	$2.08	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number includes 1,203 shares acquired under the Registrant's employee stock purchase plan on June 1, 2024.
F2	The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date.